Loratadine and Pseudoephedrine
NDC 51660-491, loratadine and pseudoephedrine, tablet, extended release, from Ohm Laboratories Inc..
- Product NDC
- 51660-491
- Status
- Listed
- Labeler
- Ohm Laboratories Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA076557
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51660-491 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LORATADINE10 mg/1
- PSEUDOEPHEDRINE SULFATE240 mg/1
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51660-491-69 | 51660049169 | 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (51660-491-69) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
NADAC price for package 51660049169
GET /v1/drugs/nadac/51660049169
Use it
Look up 51660-491 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51660-491 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51660-491. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.